Ozempic Market to Reach USD 113.95 Billion as Demand for GLP-1 Therapies Accelerates, Reports Mordor Intelligence
The Ozempic market is projected to register a CAGR of 24.89% during 2027–2032, supported by expanding diabetes treatment demand, broader metabolic health applications, and growing adoption of GLP-1 therapies. The Ozempic market is projected to register a CAGR of 24.89% during 2027–2032, supported by expanding diabetes …
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


